Modern Medicine Cases

Treating and diagnosing myopiaAndrew Morgenstern, OD, FAAO, sits down to talk myopia in children and adults, how to treat it, and how to go prevent it at the American Optometric Association’s Optometry’s Meeting in Washington, DC.
Understanding the role of inflammation in dry eyeOptometry Times Editorial Advisory Board members Leslie E. O’Dell. OD, FAAO, and Scott Hauswirth, OD, FAAO, discuss their recent lecture on inflammation and the role it plays in ocular surface diseases at the American Optometric Association’s Optometry’s Meeting in Washington, DC.
ODs must embrace new technologies, says AOA panelDisruptive technology is here to stay, and ODs must embrace it as new technologies continue to be developed and patients are eager to get their hands on them.
Top patient medications and their ocular side effectsODs must take the time to ask patients about current medication use because adverse reactions are more likely in patients who previously had allergic reactions, says Blair Lonsberry, OD, MS, MEd, FAAO, at the American Optometric Association’s Optometry’s Meeting in Washington, DC.
MACRA’s virtual groups unveiledWhile small practices now know exactly what “virtual groups” are, will they participate? Even CMS is skeptical of their success in 2018.
Wealth should not make health. Period.
Wealth should not make health. Period.In America, there is an incontrovertible truth: the richer you are, the healthier you are likely to be.
In the pipeline: What’s new and what’s coming in optometry technologyKeeping patients informed on the latest procedures and equipment available to treat their disorders is half the battle, says Paul Karpecki, OD, FAAO, at American Optometric Association’s Optometry’s Meeting.
Dara Torres: Don’t put an age limit on your dreamsDara Torres, the oldest and 12-time Olympic medalist, says your dreams shouldn’t have age limits. She addressed attendees of the American Optometric Association at Optometry's Meeting 2017, detailing her Olympic comeback after seven years away from the sport and giving birth.
Better diagnosis, treatment options key to nonresponsive bacterial keratitisNew treatment possibilities for nonresponsive bacterial keratitis are continually in development, including molecular-targeted therapy, the cautious use of topical corticosteroids, corneal crosslinking for superficial keratitis, and biologicals, Eduardo C. Alfonso, MD, reported.
Natamycin still the best bet for fungal keratitisA recent study sponsored by the National Eye Institute (NEI) of the optimal treatments for fungal keratitis showed that topical natamycin is still the mainstay of treatment. Adding oral voriconazole to the treatment regimen also may be beneficial to treat patients with Fusarium species.